Prostate Cancer
Conditions
Keywords
Decision Aid
Brief summary
The purpose of this study is to evaluate a new counseling tool for patients deciding whether or not to undergo prostate cancer screening. This screening decision aid is a computer program that provides individual patients estimates of their risks of prostate cancer diagnosis, prostate cancer related death, or death from any cause. The researchers are evaluating whether or not patients find this screening decision aid helpful. As part of this study, participants will be asked for their response on questionnaires. If patients find the screening decision aid helpful, the researchers will make it available at other clinic locations.
Detailed description
To conduct a feasibility study on implementing the computer-based screening decision aid for prostate cancer screening in a primary care setting during a 60-minute interview. To aid in informed decision making, the screening decision aid will include a graphical representation of predicted probabilities of prostate cancer diagnosis, prostate cancer-specific mortality, death from competing causes based on a man's unique demographic information. The study team will provide standardized counseling followed by individualized counseling with the screening decision aid. It will assess the quality of the decision making process (patient feels knowledgeable, informed of the risks/benefits, feels clear about their values, is involved in the decision), and quality of the decision.
Interventions
BEHAVIORALProstate cancer decision aid
Patients will undergo standardized counseling and individualized counseling with the screening decision aid. The screening decision aid is a computer program that provides individual patients estimates of their risks of prostate cancer diagnosis, prostate cancer related death, or death from any cause
Sponsors
Case Comprehensive Cancer Center
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
MALE
Age
55 Years to 69 Years
Healthy volunteers
Yes
Inclusion criteria
* Life expectancy \> 10 years * Ability to read English
Exclusion criteria
* Personal history of prostate cancer * Personal history of prostate biopsy or prostate surgery * Prior prostate specific antigen screening in the past year leading up to their scheduled clinic visit * Cognitive impairment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of initial interviews completed in 60 minutes | 60 minutes from beginning of interview | To be considered feasible in a busy clinical setting, researchers anticipate 80% of the initial interviews to be completed within the allotted 60-minute interview time. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Health Literacy | 1 month after clinical visit | Five item scale measuring attitudes towards screening |
| Patient decisional control preferences | 1 month after clinical visit | 4 item scale where lower scores indicate more positive outcomes from screening |
| Decisional conflict Scale | 1 month after clinical visit | 16 item scale ranging in a score from 0-4 where higher scores indicate more disagreement |
| Multidimensional measure of informed choice | 1 month after clinical visit | 10 item true/false scale |
| Decisional regret scale | 1 month after clinical visit | 5 item questionnaire using 5 point Likert scales where higher scores indicate more disagreement |
Countries
United States
Outcome results
None listed